findmyKOL
Clinical trialNCT06781983RecruitingPhase 1Interventional

Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors

SponsorInnate PharmaEnrollment145Advanced or Metastatic Solid Tumors
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

France
  • Centre Léon Bérard

    Lyon, France

    Armelle Vinceneux, MD
    Recruiting
  • Gustave Roussy Cancer Institute

    Villejuif, France

    Yohann Loriot, MD
    Recruiting
United States
  • Massachusetts General Hospital - Boston

    Boston, Massachusetts, United States

    Leon Pappas, MD
    Recruiting
  • John Theurer Cancer Center

    Hackensack, New Jersey, United States

    Martin Gutierrez, MD
    Recruiting
  • Mount Sinai Tisch Cancer Center

    New York, New York, United States

    Thomas Marron, MD
    Recruiting
  • Next Oncology - Dallas

    Dallas, Texas, United States

    Recruiting
  • Next Oncology - Virginia

    Fairfax, Virginia, United States

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
24 Jan 2025
Primary completion
30 Apr 2028
Completion
30 Apr 2029
Last update posted
7 Jan 2026
Registered enrollment
145
Registry id
NCT06781983

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.